Physician profile
Stephanie E Jorgensen
NPI 1083673727
$1,875.66
in general payments reported to CMS, 2019-2025
20 companies · $233 in 2025
The $233 reported for 2025 was more than what 78% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.00 · 2020: $86.48 · 2021: $184 · 2022: $347 · 2023: $447 · 2024: $488 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,168.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $337.05 | 2021-2025 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $252.13 | 2019-2024 | Jornay Pm |
| Corium, LLC | $230.50 | 2022-2025 | Azstarys |
| Sanofi Pasteur INC. | $207.81 | 2019-2023 | |
| Glaxosmithkline, LLC. | $172.84 | 2019-2025 | Bexsero, Penmenvy, Pediarix |
| Sanofi-Aventis U.S. LLC | $124.97 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $86.93 | 2022-2024 | Gardasil 9, Vaxelis, M-M-R II |
| Seqirus USA INC | $77.76 | 2022-2024 | Flucelvax Quadrivalent, Flucelvax |
| Tris Pharma INC | $45.38 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.52 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $43.56 | 2025 | Jornay Pm |
| Novo Nordisk INC | $35.92 | 2024-2025 | Wegovy |
| Abbvie INC. | $35.32 | 2020-2022 | |
| Sobi, INC | $34.42 | 2022-2023 | |
| Pfizer INC. | $32.15 | 2019-2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $27.12 | 2021 | |
| Ars Pharmaceuticals Operations, INC. | $23.91 | 2025 | Neffy |
| Hologic Sales and Service, LLC | $23.64 | 2023 | Aptima |
| Aimmune Therapeutics, INC. | $22.72 | 2022 | |
| Vertical Pharmaceuticals, LLC | $17.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Jorgensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.